Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Meitav BioTechnology Fund

+ Add to Watchlist

METBITE:IT

351.40 ILs 1.83 0.52%

As of 00:59:30 ET on 04/15/2015.

Snapshot for Meitav BioTechnology Fund (METBITE)

Year To Date: +14.59% 3-Month: +11.86% 3-Year: +32.79% 52-Week Range: 228.90 - 358.05
1-Month: +1.80% 1-Year: +54.62% 5-Year: +19.79% Beta vs TA-100: 0.70

Mutual Fund Chart for METBITE

No chart data available.
  • METBITE:IT 351.40
  • 1M
  • 1Y
Interactive METBITE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for METBITE

Meitav BioTechnology Fund is an open-end fund incorporated in Israel. The Fund invests at least 50% of it's assets in shares of Corporations from the BioTechnology industry across the globe.

Inception Date: 03-28-2000 Telephone: 972-3-777-8000
Managers: ZVI STEPAK
Web Site: www.meitavgroup.com/

Fundamentals for METBITE

NAV (on 2015-04-15) 351.40
Assets (M) (on 2015-03-31) 61.90
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for METBITE

No dividends reported

Fees & Expenses for METBITE

Front Load 0.00
Back Load -
Current Mgmt Fee 3.20
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for METBITE

Filing Date: 01/31/2015
Name Position Value % of Total
Gilead Sciences Inc 10,800 4,417,316 9.444%
iShares Nasdaq Biotechnology E 3,300 4,182,780 8.943%
First Trust NYSE Arca Biotechn 9,500 4,104,908 8.776%
SPDR S&P Biotech ETF 5,000 3,965,456 8.478%
Actavis plc 3,500 3,754,728 8.027%
Celgene Corp 6,800 3,226,842 6.899%
Novartis AG 8,000 3,114,417 6.658%
Pfizer Inc 20,000 2,499,292 5.343%
Amgen Inc 4,000 2,455,635 5.250%
Biogen Inc 1,400 1,941,603 4.151%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil